HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery
NCT ID: NCT03642093
Last Updated: 2018-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2018-08-01
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery
NCT03997162
Prehabilitation of Patients With oEsophageal Malignancy Undergoing Peri-operative Treatment
NCT03626610
Pre- and Post-Operative Exercise Program in Upper Gastrointestinal Cancers
NCT03807518
Does Prehabilitation Improve Outcome in Coloncancer Surgery?
NCT04199208
Does Prehabilitation Improve Exercise Performance and Insulin Resistance After Surgery for Oesophago-gastric Cancer?
NCT02950324
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Improved protein rich nutrition with specific immunonutrition recommendations,
2. Treatment of maldigestion or pancreatic insufficiency in pancreatic, gastric, or esophageal cancer patients,
3. Brief, evidence-based activity interventions such as walking and inspiratory muscle training (IMT), and
4. Disease specific education
These interventions should improve frailty by maintaining or regaining weight, improved grip strength, and improved prealbumin. These markers indicate improvements in nutritional status, increased strength and ability to ambulate, and improved functional status in the preoperative period. Other outcomes that will be reported include fat-soluble vitamin levels, global health, and inflammation.
The preoperative period is the best time to facilitate patient engagement through self-care and proactive activity. Interventions must be easy to accomplish and structured so patients have accountability and both patients and clinicians have methods and tools for measuring progress. Most patients and family members are motivated at this time and understand the need to improve frailty and potentially improve global health.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Frail
Subjects assessed and determined to be Frail and meet trial eligibility criteria will be enrolled on Frail Arm and begin a 4 Week program consisting of Nutritional Interventions and Physical Activity Interventions
Nutritional Intervention
Nutritional Supplementation for all subjects and Pancreatic Enzyme Replacement Therapy only for subjects with Exocrine Pancreatic Insufficiency
Physical Activity Intervention
Walking and Inspiratory Muscle Training
Not Frail
Subjects assessed and determined to be Not Frail and meet trial eligibility criteria will be enrolled on Not Frail Arm and begin a 4 Week program consisting of Nutritional Interventions and Physical Activity Interventions
Nutritional Intervention
Nutritional Supplementation for all subjects and Pancreatic Enzyme Replacement Therapy only for subjects with Exocrine Pancreatic Insufficiency
Physical Activity Intervention
Walking and Inspiratory Muscle Training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutritional Intervention
Nutritional Supplementation for all subjects and Pancreatic Enzyme Replacement Therapy only for subjects with Exocrine Pancreatic Insufficiency
Physical Activity Intervention
Walking and Inspiratory Muscle Training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients must be 25 to 80 years of age.
* All patients must have a diagnosis of cancer.
* \> 10 pound unintentional weight loss within 1 year
* Ability to perform grip strength test and Timed Up and Go (TUG) test
* Willingness to participate in the study, document compliance, and attend clinical appointments
* All patients must be undergoing one of the following major elective surgical oncologic resections with curative intent:
* Pancreaticoduodenectomy for pancreatic cancer
* Distal pancreatectomy / splenectomy for pancreatic cancer
* Esophageal robotic assisted laparoscopic thoracoscopic esophagectomy for esophageal cancer
* Laparoscopic or open, partial or total gastrectomy for gastric cancer
Exclusion Criteria
* All patients unwilling or unable to answer questionnaires or accept help to answer electronic or paper questionnaires.
* All patients that are unable to participate in an activity program.
* All patients unable to wear an electronic activity monitoring device.
* All patients not wanting to follow a specific nutritional and breathing intervention.
* All patients that are not able or wishing to consent.
25 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Siobhan Trotter
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Siobhan Trotter
Nurse Practitioner, Preoperative Optimization Program, Surgical Oncology and General Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Siobhan M Trotter, DNP
Role: PRINCIPAL_INVESTIGATOR
Ochsner Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ochsner Medical Center
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HOPE Study 2018.045
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.